5 September 2024
Oxford Nanopore Technologies
plc
Oxford
Nanopore to present at upcoming investor conferences
Oxford Nanopore Technologies plc
(LSE: ONT) ("Oxford Nanopore"), the company delivering a new
generation of nanopore-based molecular sensing technology, will be
presenting at the following investor conferences in
September.
· Goldman Sachs 21st Annual Medtech and Healthcare Services
Conference on Thursday, 5 September at 9:00am BST in London,
UK
· BofA
Securities Global Healthcare Conference 2024 on Wednesday, 18
September at 1:20pm BST in London, UK
· Bernstein's 21st Pan European Annual Strategic Decisions
Conference on Wednesday, 25 September at 9:00am BST in London,
UK
Live webcasts of the events can be
accessed at the company's investor relations page at:
https://nanoporetech.com/about/investors/reports.
Webcast replays will be available for at least 30 days following
the events via the same link.
-ENDS-
For further information, please
contact:
Oxford Nanopore Technologies plc
Investors: ir@nanoporetech.com
Media:
media@nanoporetech.com
Teneo (communications adviser to the
Company)
Tom Murray, Olivia Peters
+44 (0) 20 7353 4200
OxfordNanoporeTechnologies@teneo.com
About Oxford Nanopore Technologies plc:
Oxford Nanopore Technologies' goal
is to bring the widest benefits to society through enabling the
analysis of anything, by anyone, anywhere. The Group has developed
a new generation of nanopore-based sensing technology that is
currently used for real-time, high-performance, accessible, and
scalable analysis of DNA and RNA. The technology is used in more
than 125 countries, to understand the biology of humans, plants,
animals, bacteria, viruses and environments as well as to
understand diseases such as cancer. Oxford Nanopore's
technology also has the potential to provide broad, high impact,
rapid insights in a number of areas including healthcare, food and
agriculture.
For more information please
visit: www.nanoporetech.com
